Related Experiment Videos

[Quality of life in patients treated with beta blockers]

D Simić, N Subota

    Srpski Arhiv Za Celokupno Lekarstvo
    |June 1, 1992
    PubMed

    Insights

    Beta blockers are effective for hypertension, improving well-being and functioning. Atenolol, a hydrophilic beta blocker, shows a low incidence of central nervous system side effects.

    Area of Science:

    • Cardiology
    • Pharmacology
    • Psychology

    Context:

    • Hypertension is a primary risk factor for cardiovascular morbidity and mortality.
    • Standard treatments include diuretics, beta blockers, ACE inhibitors, and calcium-channel blockers.
    • Individualized treatment selection is crucial, particularly for mild hypertension.

    Purpose:

    • To evaluate the efficacy of beta blockers as antihypertensive agents.
    • To assess the impact of beta blockers on patients' quality of life.
    • To investigate the potential reasons for the low incidence of CNS side effects with atenolol.

    Summary:

    • Beta blockers demonstrate effectiveness in managing hypertension.
    • Treatment with beta blockers positively influences overall quality of life, encompassing well-being and psychological functioning.
    • The hydrophilic nature of atenolol may contribute to its low central nervous system (CNS) side effect profile.

    Impact:

    • Highlights the importance of individualized antihypertensive therapy.
    • Emphasizes the benefits of beta blockers beyond blood pressure reduction, including improved quality of life.
    • Suggests atenolol as a favorable option due to its favorable side effect profile and efficacy.

    Related Concept Videos

    Heart Failure Drugs: β-Blockers01:22

    Heart Failure Drugs: β-Blockers

    β-adrenergic antagonists, commonly known as β-blockers, block the effects of sympathetic neurotransmitters such as noradrenaline (NA) and adrenaline (ADR). They have several beneficial effects in heart failure treatment. They reduce heart rate, the force of contraction, and cardiac muscle relaxation. They also slow the atrial-ventricular conduction rate and raise the threshold for arrhythmias. The concentration of β-blockers determines their effects on bronchodilation, vasodilation, and...
    Adrenergic Antagonists: Pharmacological Actions of β-Receptor Blockers01:27

    Adrenergic Antagonists: Pharmacological Actions of β-Receptor Blockers

    β-receptor blockers significantly impact the cardiovascular system by counteracting catecholamine-induced sympathetic responses. These medications decrease heart rate, contractility, and cardiac output, potentially leading to cardiac depression, life-threatening bradycardia, and death. Therapeutically, β-blockers function as mild antihypertensives and are utilized in treating angina pectoris and cardiac arrhythmias. However, nonselective β-blockers inhibit β2-receptors in bronchial smooth...
    Antihypertensive Drugs: Types of β-Blockers01:28

    Antihypertensive Drugs: Types of β-Blockers

    β receptors are classified into three subclasses: β1, β2, and β3. β1 receptors are primarily located in the heart and kidneys. When they get activated, they increase heart rate, contractility, and renin release. This process enhances blood pressure and aids in stress management. In contrast, β2 receptors are situated mainly in the lungs, blood vessels, and skeletal muscles. Upon activation, they trigger smooth muscle relaxation, causing bronchodilation and vasodilation. This widens airways and...
    Adrenergic Antagonists: ɑ and β-Receptor Blockers01:31

    Adrenergic Antagonists: ɑ and β-Receptor Blockers

    Third-generation β-blockers, such as labetalol and carvedilol, represent a significant advancement in managing cardiovascular conditions. Unlike conventional β-blockers, which can induce peripheral vasoconstriction, third-generation drugs block α1 adrenoceptors. This promotes vasodilation through several mechanisms, such as increased nitric oxide production, inhibition of calcium ion entry, opening of potassium ion channels, and antioxidant action. Labetalol, for instance, is clinically...
    Cardiomyopathy V: Interprofessional Care01:29

    Cardiomyopathy V: Interprofessional Care

    Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
    Antihypertensive Drugs: Action of β1 Blockers01:17

    Antihypertensive Drugs: Action of β1 Blockers

    β1-receptors are primarily located in the heart and kidneys. In cardiac myocytes, these receptors interact with neurotransmitters released by the sympathetic nervous system during heightened activity or danger. As a result, β1-receptors get activated, initiating a series of biochemical processes. Excessive activation of beta receptors due to chronic stress can abnormally increase heart rate and contractility, resulting in high blood pressure or hypertension. To counteract this, β1-blockers...